Pacific Biosciences Of California (PACB) Net Margin Growth (3y) (2013 - 2026)
Pacific Biosciences Of California (PACB) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -641.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 941.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -1,024.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 574.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 216.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 647.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 300.00 |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | 3,209.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,209.00 |
| Mar 31, 2026 | 20,400.00 |
| Dec 31, 2025 | 21,807.00 |
| Sep 30, 2025 | 13,937.00 |
| Jun 30, 2025 | 9,586.00 |
| Mar 31, 2025 | -90,113.00 |
| Dec 31, 2024 | 19,852.00 |
| Jun 30, 2024 | -19,317.00 |
| Mar 31, 2024 | -7,027.00 |
| Dec 31, 2023 | -41,669.00 |
| Sep 30, 2023 | 417.00 |
| Jun 30, 2023 | 32,854.00 |
| Mar 31, 2023 | -1,059.00 |
| Dec 31, 2022 | -23,900.00 |
| Sep 30, 2022 | -10,690.00 |
| Jun 30, 2022 | -9,966.00 |
| Mar 31, 2022 | -5,126.00 |
| Dec 31, 2021 | -3,243.00 |
| Jun 30, 2021 | -15,263.00 |
| Mar 31, 2021 | 19,509.00 |